Telomir Pharmaceuticals Secures Global Rights to Telomir-1

New York, Tuesday, 21 October 2025.
Telomir Pharmaceuticals signed a binding LOI for global rights to Telomir-1, positioning it for market expansion with potential $5 million shareholder contributions and strategic partnerships.